The Global Alliance for TB Drug Development (TB Alliance) and Novartis Institute for Tropical Diseases (NITD) announced their plans to
NEW YORK, NY – OCT 20, 2004 – The Global Alliance for TB Drug Development (TB Alliance), a public-private partnership
New Donor Brings Support for Innovative Drug Development to $50 million The United States Agency for International Development (USAID), the
TB Alliance Adds New Member to Research & Development Team The Global Alliance for TB Drug Development (TB Alliance), a
TB Alliance Adds New Member to Research & Development Team The Global Alliance for TB Drug Development (TB Alliance), a
TB Alliance Bolsters Research & Development Team The TB Alliance has announced the appointment of Dr. Ann Ginsberg as Head
WHAT: Release of startling findings from the latest World Health Organization report on multi-drug-resistant strains in tuberculosis (MDR-TB): A total
Veteran of Academia and Industry brings 20-plus years of expertise to International Public-Private Partnership The TB Alliance has announced the
The TB Alliance reached another important milestone in the portfolio building process on April 22. We announced the launch of
New Tuberculosis Drugs Required o Eliminate Epidemic, Meet Economic Development Goals Health Experts Urge Public & Industry Commitments New York,
